BCRX EPS Estimates
BioCryst Pharmaceuticals, Inc.
$7.69
+$0.06(+0.79%)
50
Overall
60
Value
40
Tech
50
Quality
Market Cap
$1.98B
Volume
5.21M
52W Range
$6.23 - $11.22
Target Price
$20.27
BCRX EPS estimates: the consensus estimate for BioCryst Pharmaceuticals, Inc.'s current fiscal year is -$2.28 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
BCRX EPS Estimates
- EPS estimate, current quarter
- $0.10
- EPS estimate, next quarter
- $0.11
- EPS estimate, current year
- $-2.28
- EPS estimate, next year
- $0.72
- EPS growth, 3-year
- +0.00%
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $7.69 | +0.8% | 5.21M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW